These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16571703)

  • 21. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should North America's first and only supervised injection facility (InSite) be expanded in British Columbia, Canada?
    Jozaghi E; Andresen MM
    Harm Reduct J; 2013 Feb; 10():1. PubMed ID: 23414093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
    Kuyper LM; Kerr T; Li K; Hogg RS; Tyndall MW; Montaner JS; Wood E
    Subst Use Misuse; 2006; 41(6-7):883-99. PubMed ID: 16809177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
    Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
    Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
    Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
    Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent incarceration independently associated with syringe sharing by injection drug users.
    Wood E; Li K; Small W; Montaner JS; Schechter MT; Kerr T
    Public Health Rep; 2005; 120(2):150-6. PubMed ID: 15842116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    Int J Drug Policy; 2008 Jun; 19(3):220-5. PubMed ID: 18551754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
    Krüsi A; Small W; Wood E; Kerr T
    AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
    Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
    Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of safer injection facilities in the response to HIV/AIDS among injection drug users.
    Kerr T; Kimber J; Debeck K; Wood E
    Curr HIV/AIDS Rep; 2007 Dec; 4(4):158-64. PubMed ID: 18366946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
    Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
    Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The initial experience in supervised injecting facilities in Denmark].
    Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
    Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
    Davidson PJ; Lopez AM; Kral AH
    Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime.
    Wood E; Tyndall MW; Lai C; Montaner JS; Kerr T
    Subst Abuse Treat Prev Policy; 2006 May; 1():13. PubMed ID: 16722550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
    Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
    Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.